69 related articles for article (PubMed ID: 15897892)
1. The MCT-1 oncogene product impairs cell cycle checkpoint control and transforms human mammary epithelial cells.
Hsu HL; Shi B; Gartenhaus RB
Oncogene; 2005 Jul; 24(31):4956-64. PubMed ID: 15897892
[TBL] [Abstract][Full Text] [Related]
2. Expression and stabilization of the MCT-1 protein by DNA damaging agents.
Herbert GB; Shi B; Gartenhaus RB
Oncogene; 2001 Oct; 20(46):6777-83. PubMed ID: 11709712
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of MCT-1 by p44/42 MAPK is required for its stabilization in response to DNA damage.
Nandi S; Reinert LS; Hachem A; Mazan-Mamczarz K; Hagner P; He H; Gartenhaus RB
Oncogene; 2007 Apr; 26(16):2283-9. PubMed ID: 17016429
[TBL] [Abstract][Full Text] [Related]
4. A novel candidate oncogene, MCT-1, is involved in cell cycle progression.
Prosniak M; Dierov J; Okami K; Tilton B; Jameson B; Sawaya BE; Gartenhaus RB
Cancer Res; 1998 Oct; 58(19):4233-7. PubMed ID: 9766643
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic transformation of human mammary epithelial cells by autocrine human growth hormone.
Zhu T; Starling-Emerald B; Zhang X; Lee KO; Gluckman PD; Mertani HC; Lobie PE
Cancer Res; 2005 Jan; 65(1):317-24. PubMed ID: 15665309
[TBL] [Abstract][Full Text] [Related]
6. Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity.
Kasiappan R; Shih HJ; Chu KL; Chen WT; Liu HP; Huang SF; Choy CO; Shu CL; Din R; Chu JS; Hsu HL
Mol Cancer Res; 2009 Apr; 7(4):536-48. PubMed ID: 19372582
[TBL] [Abstract][Full Text] [Related]
7. MCT-1 oncogene downregulates p53 and destabilizes genome structure in the response to DNA double-strand damage.
Hsu HL; Choy CO; Kasiappan R; Shih HJ; Sawyer JR; Shu CL; Chu KL; Chen YR; Hsu HF; Gartenhaus RB
DNA Repair (Amst); 2007 Sep; 6(9):1319-32. PubMed ID: 17416211
[TBL] [Abstract][Full Text] [Related]
8. MCT-1 protein interacts with the cap complex and modulates messenger RNA translational profiles.
Reinert LS; Shi B; Nandi S; Mazan-Mamczarz K; Vitolo M; Bachman KE; He H; Gartenhaus RB
Cancer Res; 2006 Sep; 66(18):8994-9001. PubMed ID: 16982740
[TBL] [Abstract][Full Text] [Related]
9. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
10. Analysis of dystroglycan regulation and functions in mouse mammary epithelial cells and implications for mammary tumorigenesis.
Sgambato A; Di Salvatore MA; De Paola B; Rettino A; Faraglia B; Boninsegna A; Graziani C; Camerini A; Proietti G; Cittadini A
J Cell Physiol; 2006 May; 207(2):520-9. PubMed ID: 16447256
[TBL] [Abstract][Full Text] [Related]
11. Early upregulation of cyclooxygenase-2 in human papillomavirus type 16 and telomerase-induced immortalization of human esophageal epithelial cells.
Zhuang ZH; Tsao SW; Deng W; Wang JD; Xia HH; He H; Feng HC; Wang LD; Gu Q; Lam SK; Lin MC; Kung HF; Wong BC
J Gastroenterol Hepatol; 2008 Oct; 23(10):1613-20. PubMed ID: 18717758
[TBL] [Abstract][Full Text] [Related]
12. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.
Yuan B; Xu Y; Woo JH; Wang Y; Bae YK; Yoon DS; Wersto RP; Tully E; Wilsbach K; Gabrielson E
Clin Cancer Res; 2006 Jan; 12(2):405-10. PubMed ID: 16428479
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.
Fernàndez V; Hartmann E; Ott G; Campo E; Rosenwald A
J Clin Oncol; 2005 Sep; 23(26):6364-9. PubMed ID: 16155021
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta1 induces epithelial-to-mesenchymal transition and apoptosis via a cell cycle-dependent mechanism.
Yang Y; Pan X; Lei W; Wang J; Song J
Oncogene; 2006 Nov; 25(55):7235-44. PubMed ID: 16799646
[TBL] [Abstract][Full Text] [Related]
16. Targeted suppression of MCT-1 attenuates the malignant phenotype through a translational mechanism.
Mazan-Mamczarz K; Hagner P; Dai B; Corl S; Liu Z; Gartenhaus RB
Leuk Res; 2009 Mar; 33(3):474-82. PubMed ID: 18824261
[TBL] [Abstract][Full Text] [Related]
17. Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation.
Yang MH; Chiang WC; Chou TY; Chang SY; Chen PM; Teng SC; Wu KJ
Clin Cancer Res; 2006 Jan; 12(2):507-15. PubMed ID: 16428493
[TBL] [Abstract][Full Text] [Related]
18. Cigarette smoke condensate-induced transformation of normal human breast epithelial cells in vitro.
Narayan S; Jaiswal AS; Kang D; Srivastava P; Das GM; Gairola CG
Oncogene; 2004 Aug; 23(35):5880-9. PubMed ID: 15208684
[TBL] [Abstract][Full Text] [Related]
19. Isogenic normal basal and luminal mammary epithelial isolated by a novel method show a differential response to ionizing radiation.
Huper G; Marks JR
Cancer Res; 2007 Apr; 67(7):2990-3001. PubMed ID: 17409405
[TBL] [Abstract][Full Text] [Related]
20. Constitutive overexpression of CDC25A in primary human mammary epithelial cells results in both defective DNA damage response and chromosomal breaks at fragile sites.
Cangi MG; Piccinin S; Pecciarini L; Talarico A; Dal Cin E; Grassi S; Grizzo A; Maestro R; Doglioni C
Int J Cancer; 2008 Sep; 123(6):1466-71. PubMed ID: 18566993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
